Skip to main content.

Coronavirus Files: FDA issues historic Pfizer authorization, ICUs fill up, infection in five minutes

Coronavirus Files: FDA issues historic Pfizer authorization, ICUs fill up, infection in five minutes

Picture of Chinyere Amobi

 

Since April, The Center for Health Journalism has been publishing a special newsletter geared to journalists as they report on one of the biggest and most complex stories of our times. Each Monday, while the pandemic runs its course, The Coronavirus Files will provide tips and resources and highlight exemplary work to help you with your coverage. This week, the Center for Health Journalism’s Coronavirus Files Monday newsletter is curated and reported by CHJ community editor Chinyere Amobi. Have a suggestion or a request? Write us at editor@centerforhealthjournalism.org.

 

FDA issues historic Pfizer vaccine authorization

“The Food and Drug Administration on Friday issued an emergency authorization for a Covid-19 vaccine developed by Pfizer and its German partner, BioNTech, a seminal moment in the effort to curb a pandemic that has so far infected an estimated 16 million people and killed nearly 300,000 in the United States,” writes Helen Branswell of STAT.
 
The FDA accelerated its timeline to issue the authorization for the Pfizer vaccine on Friday evening after Trump chief of staff Mark Meadows threatened the job of Dr. Stephen M. Hahn, the agency’s leader. An advisory panel of experts had already recommended the vaccine for emergency authorization on Thursday evening, so the added pressure was unlikely to affect the outcome of the approval process. “But it nonetheless showed that even at the 11th hour, the White House was unwilling to allow regulators the independence to work according to their own plan as they processed key documents, including instructions to physicians for use of the vaccine and a fact sheet on the product,” The New York Times reports. Two other Western countries — the United Kingdom and Canada — have approved the Pfizer vaccine for use.
 
“Pfizer has said it will have about 25 million doses of the two-shot vaccine for the U.S. by the end of December,” write Lauran Neergaard and Matthew Perrone of The Associated Press. Initial doses will be reserved for health care workers and nursing home residents. The vaccine is unlikely to be widely available on demand for the general public until spring 2021. 
 

Trump administration passed on chance to secure additional vaccine doses from Pfizer

“Before Pfizer’s coronavirus vaccine was proven highly successful in clinical trials last month, the company offered the Trump administration the chance to lock in supplies beyond the 100 million doses the pharmaceutical maker agreed to sell the government as part of a $1.95 billion deal over the summer,” The New York Times reported last Monday. The administration passed on that chance, raising questions about whether the U.S. will have an adequate supply of the two-dose vaccine for the general public next year. Pfizer has since signed deals, including with the European Union, which secured 200 million doses. While Trump has mentioned plans to sign an executive order to ensure that other countries will not get the vaccine until all Americans are vaccinated, “the executive order by itself appears to have no real teeth and does not expand the U.S. supply of doses,” write Sharon LaFraniere, Katie Thomas and Noah Weiland of The New York Times. 

Dr. Moncef Slaoui, who is leading the government’s vaccine effort, told Good Morning America that the administration had been looking at several vaccine candidates over the summer before the deal was made and was reluctant to buy too much of a vaccine whose effectiveness was uncertain. 

ICUs around the country are filling up, halfway through the holiday season

New data released by the Department of Health and Human Services on Monday gives the most detailed picture to date of how COVID-19 is stressing individual hospitals in the United States,” said Sean McMinn and Pien Huang during NPR’s Monday Morning Edition. This is the first time the department has released COVID-19 data at the facility level, painting a more accurate picture of how hospitals around the country are coping with the current surge in coronavirus cases. By highlighting regional hotspots, the data can identify areas of hospital strain even in states that are doing well overall. Key findings from the data include high levels of strain in both large and small hospitals. The states with the most counties above a 90% capacity threshold: Kentucky, Georgia, Minnesota, Oklahoma and Texas. 

While public health experts initially raised concerns about political influence when HHS took control of pandemic data from the CDC, hospital reporting has improved in recent months. What remains to be seen is a link between reliable data and the federal government’s response to the pandemic. 

Some counties in California’s agricultural region hit full capacity last week, and the country continues to experience a surge in COVID-19 cases following the Thanksgiving holiday. “I don’t think we’ve seen the peak,” Dr. Rais Vohra, Fresno County Department of Public Health, told the Los Angeles Times. “I think the peak is yet to come, and I’m very concerned that our hospitals will not be able to meet the demands that will be placed on them.” Health officials around the country are urging Americans to stay home in the next few weeks, fearing a surge upon a surge as Christmas approaches. 

Seoul student infected with COVID-19 after 5 minutes of indoor exposure 

A new study published in the Journal of Korean Medical Science found that a South Korean student contracted COVID-19 from an out-of-towner in a restaurant after only five minutes of exposure from 20 feet away. “The conclusions raised concerns that the widely accepted standard of six feet of social distance may not be far enough to keep people safe,” writes Victoria Kim of the Los Angeles Times. The study’s authors wrote that “quarantine and epidemiological investigation” guidelines must be updated to reflect the increased range of potential exposure from aerosolized droplets while indoors. Study authors relied on contact tracers, the country’s Epidemic Investigation Support System and even an aerodynamics engineer to solve the mystery of how the high school student contracted the virus in a town that hadn’t seen any new cases in two months. These findings could (and should) have real implications for how Americans behave during the colder months ahead. 

From the Center for Health Journalism: Aging and Alone During COVID-19

Join the Center for Heath Journalism for a free webinar on Wednesday, December 16 at 10 a.m. PT / 1 p.m. ET, where we’ll talk about how loneliness and social isolation impact older Americans, how the pandemic has exacerbated the crisis beyond measure, and what programs stand to help the most. Journalists will benefit from fresh story ideas and durable insights for covering an issue that is undermining the health and well-being of seniors in every community. Our expert panel includes Paula Span, author of the New Old Age column for The New York Times; Dr. Carla Perissinotto, a geriatrician and palliative care physician at UCSF; and Laura Trejo, general manager of the Department of Aging for the city of Los Angeles. Sign up here: https://bit.ly/3n02Mo7

 

What we’re reading 

 

Resources & events

Leave A Comment

Announcements

Join us to hear from two of the best on the COVID beat: Helen Branswell of STAT and Katherine J. Wu of The Atlantic will share their strategies and tips for staying ahead of an ever-changing story. Sign-up here!

Our California Fellowship supports reporters in the Golden State pursuing ambitious projects on overlooked health and health equity issues.

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth